Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

From Alzheimer's prevention to weight-loss dominance, Novo bets on innovation and share repurchases amid Medicare pressure.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

A letter from several Democratic Senators urged Trump to use his deal-making skills to “flat out reject any request to end ...

Minnesota Attorney General Keith Ellison says he will announce "a major development in his litigation against the three largest insulin manufacturers" on Monday morning.

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly out-of-pocket price cap, which is set by law.

A group of lawmakers are urging President Donald Trump to reject pharmaceutical companies’ efforts to pause the Biden ...

Medicare’s $35 insulin price cap was signed ... In 2023, insulin manufacturer Eli Lilly voluntarily capped out-of-pocket costs for its insulin at $35 at participating pharmacies for people ...